The Cell Therapy Industry Summit

Program Highlight

The Cell Therapy Industry Summit will provide an excellent opportunity for thought leaders to celebrate cell therapy industry achievements and disseminate best practices. The meeting is designed specifically to serve the networking and informational needs of cell therapy industry leaders and limited in attendance to ensure participants are able to engage in meaningful discussions about mutually beneficial industry trends, dynamics and opportunities.

Agenda at Glance
Distinguished Speakers

WEDNESDAY, NOVEMBER 3
6:00pm - 9:00pm	Pre-conference networking event & cocktail reception
THURSDAY, NOVEMBER 4
7:00am - 8:00am	Breakfast
8:00am - 10:00am	Session 1: Leading in regenerative medicine.
	• Financing regenerative medicine • Partnering for growth • Leading the post-approval business
10:00am - 10:30am	Morning Coffee
10:30am - 12:00pm	Session 2: Building a regenerative medicine enterprise
	• Cells as therapy – making the case • Alliance building – when & how to do it • Managing regenerative medicine risks
12:00pm - 1:00pm	Lunch
1:00pm - 2:30pm	Breakout Sessions
Session 1: Designing regenerative medicine innovations with translation in mind • Strategies for moving concepts from ‘bench to bedside’ • Building a regulatory compliant path in uncharted waters • The "academic pipeline" - best practices Session 2: Leveraging cutting edge technologies to change the cell therapy manufacturing paradigm • Current technologies for stem cell manufacturing scale up • Internal culture system design: benefits and challenges • Fitting novel technologies into clinical and commercial manufacturing Session 3: Assessing & implementing automation: • Timing for bringing in automation • Cost effectiveness of automation • Where in the process automation can help
2:30pm - 3:00pm	Afternoon Break
3:00pm - 5:00pm	Session 3: Marketing and distribution of regenerative medicine products.
	• Go to market strategies • Distribution & logistics considerations • Payers and reimbursement
5:30pm - 8:00pm	Networking reception and Dinner

FRIDAY, NOVEMBER 5
7:00am - 8:00am	Breakfast
8:00am - 10:00am	Session 1: Overcoming global regulatory hurdles
	• Aligning on common standards • Operational impacts of differing regulatory environments • Implementing technology to open new markets
10:00am - 10:30am	Morning Coffee
10:30am - 12:00pm	Session 2: Building a regenerative medicine business - Asia Pacific focus
	• Business model selection • Speed to market through technology alliances • Meeting market demand

Greg Lucier, Chairman and CEO , Life Technologies Corporation
John S. West, President and CEO, ViaCyte, Inc.
Kevin Rakin, Chairman and CEO, Advanced BioHealing Inc.
Gil Van Bokkelen, Chairman and CEO, Athersys Inc.
Keith Murphy, CEO and President, Organovo
David Newble, CEO, The Automation Partnership
David J. Earp, Chief Patent Counsel and Senior Vice President, Business Development, Geron Corporation
Frederick M. Miesowicz, COO, Argos Therapeutics
Ronnda L. Bartel, CSO, Aastrom Biosciences
Wilfried Dalemans, CTO, TiGenix
Dean Tozer, Senior Vice President, Advanced BioHealing, Inc.
Nathalie Dusserre, Vice President of Manufacturing and Regulatory Affairs, Cytograft Tissue Engineering
Leslie Wolfe, Vice President, Technology Development, Genzyme Corporation
Umesh Baikunje, Sr. General Manager, Quality and Regulatory Affairs, Stempeutics Research Pvt. Ltd.
Patricia Olson, Executive Director, Scientific Activities, California Institute for Regenerative Medicine
Greg Russotti, Senior Director for Process Development, Celgene Cellular Therapeutics
Carl H. June, Director, Translational Research and Professor, Department of Pathology and Laboratory Medicine, University of Pennsylvania
Katie Faria, Director of Process Development, Organogenesis Inc.